OSAM
LGND icon

O'Shaughnessy Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

O'Shaughnessy Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,784
Closed -$242K – 1914
2021
Q3 		$242K Sell
2,784
-3,194
-53% -$247K ﹤0.01% 950
2021
Q2 		$489K Buy
5,978
+400
+7% +$33.3K 0.01% 668
2021
Q1 		$530K Sell
5,578
-645
-10% -$61K 0.01% 587
2020
Q4 		$386K Buy
6,223
+5,886
+1,747% +$336K 0.01% 594
2020
Q3 		$20K Sell
337
-1,356
-80% -$92.5K ﹤0.01% 1248
2020
Q2 		$118K Sell
1,693
-4,123
-71% -$261K ﹤0.01% 799
2020
Q1 		$264K Sell
5,816
-1,309
-18% -$74.2K 0.01% 401
2019
Q4 		$464K Sell
7,125
-436
-6% -$29.1K 0.01% 418
2019
Q3 		$470K Buy
7,561
+4,062
+116% +$255K 0.01% 383
2019
Q2 		$249K Sell
3,499
-4,040
-54% -$298K 0.01% 504
2019
Q1 		$588K Sell
7,539
-13,643
-64% -$1.03M 0.01% 342
2018
Q4 		$1.8M Sell
21,182
-1,723
-8% -$184K 0.05% 196
2018
Q3 		$3.89M Buy
22,905
+9,113
+66% +$1.37M 0.08% 142
2018
Q2 		$1.77M Buy
13,792
+5,615
+69% +$627K 0.04% 200
2018
Q1 		$843K Buy
8,177
+1,600
+24% +$158K 0.02% 269
2017
Q4 		$562K Buy
6,577
+2,853
+77% +$247K 0.01% 363
2017
Q3 		$316K Buy
+3,724
New +$295K 0.01% 437
2014
Q3 		– Sell
-138
Closed -$5K – 1022
2014
Q2 		$5K Hold
138
– – ﹤0.01% 847
2014
Q1 		$6K Hold
138
– – ﹤0.01% 813
2013
Q4 		$5K Sell
138
-131
-49% -$4.27K ﹤0.01% 832
2013
Q3 		$7K Buy
+269
New +$7.57K ﹤0.01% 782

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

O'Shaughnessy Asset Management's LGND Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2021, closing a stake of 2,784 shares — an estimated $242K sold.

O'Shaughnessy Asset Management first reported a position in LGND in Q3 2013 and held it in 21 quarters. The position peaked at $3.89M in Q3 2018. 221 funds tracked by Wall St. Rank hold LGND as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Ligand Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 2,784 Ligand Pharmaceuticals shares in Q4 2021, an estimated $242K.
  • O'Shaughnessy Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2013 and held it in 21 quarters.
  • O'Shaughnessy Asset Management's Ligand Pharmaceuticals position peaked at $3.89M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.